Advanced search
Publication Cover
Journal of Enzyme Inhibition and Medicinal Chemistry Volume 37, 2022 - Issue 1
Submit an article Journal homepage
2,589
Views
8
CrossRef citations to date
0
Altmetric
Brief Report

Second generation β-elemene nitric oxide derivatives with reasonable linkers: potential hybrids against malignant brain glioma

Renren Baia School of Pharmacy, Hangzhou Normal University, Hangzhou, Zhejiang, China;b Key Laboratory of Elemene Class Anti-Cancer Chinese Medicine of Zhejiang Province, Engineering Laboratory of Development and Application of Traditional Chinese Medicine from Zhejiang Province, Collaborative Innovation Center of Chinese Medicines from Zhejiang Province, Hangzhou Normal University, Hangzhou, ChinaCorrespondence[email protected] [email protected]
View further author information
,
Junlong Zhua School of Pharmacy, Hangzhou Normal University, Hangzhou, Zhejiang, China;b Key Laboratory of Elemene Class Anti-Cancer Chinese Medicine of Zhejiang Province, Engineering Laboratory of Development and Application of Traditional Chinese Medicine from Zhejiang Province, Collaborative Innovation Center of Chinese Medicines from Zhejiang Province, Hangzhou Normal University, Hangzhou, ChinaView further author information
,
Ziqiang Baia School of Pharmacy, Hangzhou Normal University, Hangzhou, Zhejiang, China;b Key Laboratory of Elemene Class Anti-Cancer Chinese Medicine of Zhejiang Province, Engineering Laboratory of Development and Application of Traditional Chinese Medicine from Zhejiang Province, Collaborative Innovation Center of Chinese Medicines from Zhejiang Province, Hangzhou Normal University, Hangzhou, ChinaView further author information
,
Qing Maoa School of Pharmacy, Hangzhou Normal University, Hangzhou, Zhejiang, China;b Key Laboratory of Elemene Class Anti-Cancer Chinese Medicine of Zhejiang Province, Engineering Laboratory of Development and Application of Traditional Chinese Medicine from Zhejiang Province, Collaborative Innovation Center of Chinese Medicines from Zhejiang Province, Hangzhou Normal University, Hangzhou, ChinaView further author information
,
Yingqian Zhanga School of Pharmacy, Hangzhou Normal University, Hangzhou, Zhejiang, China;b Key Laboratory of Elemene Class Anti-Cancer Chinese Medicine of Zhejiang Province, Engineering Laboratory of Development and Application of Traditional Chinese Medicine from Zhejiang Province, Collaborative Innovation Center of Chinese Medicines from Zhejiang Province, Hangzhou Normal University, Hangzhou, ChinaView further author information
,
Zi Huia School of Pharmacy, Hangzhou Normal University, Hangzhou, Zhejiang, China;b Key Laboratory of Elemene Class Anti-Cancer Chinese Medicine of Zhejiang Province, Engineering Laboratory of Development and Application of Traditional Chinese Medicine from Zhejiang Province, Collaborative Innovation Center of Chinese Medicines from Zhejiang Province, Hangzhou Normal University, Hangzhou, ChinaView further author information
,
Xinyu Luoa School of Pharmacy, Hangzhou Normal University, Hangzhou, Zhejiang, China;b Key Laboratory of Elemene Class Anti-Cancer Chinese Medicine of Zhejiang Province, Engineering Laboratory of Development and Application of Traditional Chinese Medicine from Zhejiang Province, Collaborative Innovation Center of Chinese Medicines from Zhejiang Province, Hangzhou Normal University, Hangzhou, ChinaView further author information
,
Xiang-Yang Yea School of Pharmacy, Hangzhou Normal University, Hangzhou, Zhejiang, China;b Key Laboratory of Elemene Class Anti-Cancer Chinese Medicine of Zhejiang Province, Engineering Laboratory of Development and Application of Traditional Chinese Medicine from Zhejiang Province, Collaborative Innovation Center of Chinese Medicines from Zhejiang Province, Hangzhou Normal University, Hangzhou, ChinaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0003-3739-0930View further author information
ORCID Icon &
Tian Xiea School of Pharmacy, Hangzhou Normal University, Hangzhou, Zhejiang, China;b Key Laboratory of Elemene Class Anti-Cancer Chinese Medicine of Zhejiang Province, Engineering Laboratory of Development and Application of Traditional Chinese Medicine from Zhejiang Province, Collaborative Innovation Center of Chinese Medicines from Zhejiang Province, Hangzhou Normal University, Hangzhou, ChinaCorrespondence[email protected]
View further author information
 show all
Pages 379-385 | Received 25 Oct 2021, Accepted 05 Dec 2021, Published online: 10 Jan 2022

References:

  • Huang ZJ, Fu JJ, Zhang YH. Nitric oxide donor-based cancer therapy: advances and prospects. Eur J Med Chem 2017;60:7617–35.
  • Xiang QQ, Qiao B, Luo YL, et al. Increased photodynamic therapy sensitization in tumors using a nitric oxide-based nanoplatform with ATP-production blocking capability. Theranostics 2021;11:1953–69.
  • Wong A, Hu NX, Tian XC, et al. Nitric oxide sensing revisited. Trends Plant Sci 2021;26:885–97.
  • Kleschyov AL, Oelze M, Daiber A, et al. Does nitric oxide mediate the vasodilator activity of nitroglycerin? Circ Res 2003;93:e104–e112.
  • Horton A, Schiefer IT. Pharmacokinetics and pharmacodynamics of nitric oxide mimetic agents. Nitric Oxide 2019;84:69–78.
  • Feelisch M, Schönafinger K, Noack E. Thiol-mediated generation of nitric oxide accounts for the vasodilator action of furoxans. Biochem Pharmacol 1992;44:1149–57.
  • Bai ZQ, Yao CS, Zhu JL, et al. Anti-tumor drug discovery based on natural product beta-elemene: anti-tumor mechanisms and structural modification. Molecules 2021;26:1499.
  • Chen JC, Wang TY, Xu ST, et al. Discovery of novel antitumor nitric oxide-donating β-elemene hybrids through inhibiting the PI3K/Akt pathway. Eur J Med Chem 2017;135:414–23.
  • Chen JC, Duan WL, Bai RR, et al. Synthesis of 13-β-elemene ester derivatives and evaluation of their antioxidant activity in human umbilical vein endothelial cells. Chin J Nat Med 2015;13:618–27.
  • Cheng HB, Ge XY, Zhuo SQ, et al. β-Elemene synergizes with Gefitinib to inhibit stem-like phenotypes and progression of lung cancer via down-regulating EZH2. Front Pharmacol 2018;9:1413.
  • Wang XW, Liu ZT, Sui XB, et al. Elemene injection as adjunctive treatment to platinum-based chemotherapy in patients with stage III/IV non-small cell lung cancer: a meta-analysis following the PRISMA guidelines. Phytomedicine 2019;59:152787.
  • He XR, Zhuo XT, Gao Y, et al. β-Elemene derivatives produced from SeO2-mediated oxidation reaction. R Soc Open Sci 2020;7:200038.
  • Bai RR, Jie XE, Salgado J, et al. Design, discovery, rational design, synthesis and biological evaluation of novel derivatives based on in vivo metabolism of natural product β-elemene. Lett Drug Des Discov 2018;15: 905–12.
  • Chen JC, Duan WL, Bai RR, et al. Design, synthesis and antioxidant activity evaluation of novel β-elemene derivatives. Bioorg Med Chem Lett 2014;24:3407–11.
  • Zhai BT, Zhang NN, Han XM, et al. Molecular targets of β-elemene, a herbal extract used in traditional Chinese medicine, and its potential role in cancer therapy: a review. Biomed Pharmacother 2019;114:108812.
  • Stupp R, Mason WP, van den Bent MJ, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 2005;352:987–96.
  • Bai RR, Yang X, Zhu Y, et al. Novel nitric oxide-releasing isochroman-4-one derivatives: synthesis and evaluation of antihypertensive activity. Bioorg Med Chem 2012;20:6848–55.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.